Dr Gisela Mautner has pharmaceutical industry experience covering all aspects from clinical research through to product commercialisation.
She has held senior leadership positions at MSD, Bayer and Amgen where she launched several new drugs in different therapeutic areas.
In her early career, Dr Mautner was a clinical scientist at the National Institutes of Health in the USA. Dr Mautner has engaged with the pharmaceutical community and has served on the Executive Committee of APPA (Australian Pharmaceutical Medical and Scientific Professionals Association) for numerous years. She recently handed over her presidency of APPA and continues to serve as past president to promote excellence within the pharmaceutical community.